MedPath

Purple pitcher plant

Generic Name
Purple pitcher plant
Drug Type
Biotech
Unique Ingredient Identifier
FOP08H143P

Overview

Sarracenia purpurea, commonly known as the purple pitcher plant, northern pitcher plant, turtle socks, or side-saddle flower, is a perennial carnivorous plant in the family Sarraceniaceae. Sarracenia purpurea attract and trap insects within their pitchers, or fused leaves, to consume nitrogen during the digestion process . It is widely distributed across North America and has been used as a traditional medicinal herb in many aboriginal communities . It was used as an injectable pain reliever and during the 19th century, Sarracenia purpurea was used as a treatment of smallpox . Compounds extracted from Sarracenia purpurea include phenolic glycosides, flavonoid glycosides, and iridoids. In vitro, there is evidence of glycosides potentiating glucose uptake with potential antidiabetic properties . Cytoprotection in an in vitro model of diabetic neuropathy has also been studied. However, the use of Sarracenia Purpurea extracts in the clinical setting are limited.

Indication

No approved therapeutic indications.

Associated Conditions

  • Pain

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Deseret Biologicals, Inc.
43742-2263
ORAL
12 [hp_X] in 1 mL
5/7/2025
Deseret Biologicals, Inc.
43742-2108
ORAL
12 [hp_X] in 1 mL
5/27/2025
Newton Laboratories, Inc.
55714-4748
ORAL
15 [hp_X] in 1 mL
8/20/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
SARAPIN
high chemical company
00226882
Solution - Intramuscular
100 %
12/31/1942
SARRACENIA PURPUREA GRAN (1CH-30CH)
homeocan inc.
01952846
Tablet - Oral
1 CH / TAB
12/31/1991
NEPENTHES GRANULES 1DH-30CH
dolisos laboratoires s.a.
00769703
Tablet - Oral
1 DH / DH
12/31/1988
NEPENTHES
dolisos canada inc.
02234628
Granules ,  Globules ,  Liquid - Oral
1 X
1/5/1998

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.